Close
  Indian J Med Microbiol
 

Figure 3: Effect of herniarin treatment on lipids and lipoprotein levels. Where (a) estimation of plasma lipids (TG, PL, TC, FC, FFA, and EC) and (b) Estimation of plasma lipoproteins (HDL-C, LDL-C, and VLDL-C) in all experimental groups of animals where each value shows mean ± standard error of mean (n = 6); comparisons: a – Groups II, III, and IV compared with Group I; b – Groups III and IV compared to Group II; ***P < 0.001; **P < 0.01; *P < 0.05;nsP > 0.05; Group I – Control; Group II – Induced control (DMBA, 20 mg); Group III – DMBA (20 mg) + herniarin (20 mg/kg, b. w.); Group IV – DMBA (20 mg) + herniarin (40 mg/kg b. w.). DMBA: 7,12-dimethylbenz(a)anthracene; TG: Triglyceride; PL: Phospholipid; TC: Total cholesterol; FC: Free cholesterol; FFA: Free fatty acid; EC: Ester cholesterol; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol; VLDL-C: Very-low-density lipoprotein-cholesterol

Figure 3: Effect of herniarin treatment on lipids and lipoprotein levels. Where (a) estimation of plasma lipids (TG, PL, TC, FC, FFA, and EC) and (b) Estimation of plasma lipoproteins (HDL-C, LDL-C, and VLDL-C) in all experimental groups of animals where each value shows mean ± standard error of mean (<i>n</i> = 6); comparisons: a – Groups II, III, and IV compared with Group I; b – Groups III and IV compared to Group II; ***<i>P</i> < 0.001; **<i>P</i> < 0.01; *<i>P</i> < 0.05;<sup>ns</sup><i>P</i> > 0.05; Group I – Control; Group II – Induced control (DMBA, 20 mg); Group III – DMBA (20 mg) + herniarin (20 mg/kg, b. w.); Group IV – DMBA (20 mg) + herniarin (40 mg/kg b. w.). DMBA: 7,12-dimethylbenz(a)anthracene; TG: Triglyceride; PL: Phospholipid; TC: Total cholesterol; FC: Free cholesterol; FFA: Free fatty acid; EC: Ester cholesterol; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol; VLDL-C: Very-low-density lipoprotein-cholesterol